Influence of aldosterone synthetase (CYP11B2) gene polymorphism upon the risk of myocardial infarction
Article Sidebar
Main Article Content
Abstract
The aim – to determine the effect of certain variant of aldosterone synthase gene polymorphism (CYP11B2) upon the risk of myocardial infarction (MI) in postinfarction patients compared to the patients with stable coronary heart disease without previous MI, patients at high cardiovascular risk and healthy volunteers.
Material and methods. 378 subjects examined by general clinical methods were divided into four groups:
100 patients with postinfarction cardiosclerosis, 78 patients with coronary artery disease without a history of heart attack, 100 high cardiovascular risk patients and 100 healthy subjects. Genetic testing was performed by polymerase chain reaction in real time. The comparison of groups was performed regarding aldosterone synthase (CYP11B2) gene polymorphism.
Results. During genotyping CYP11B2 –344C/T polymorphism in postinfarction patients the following relationship was shown: TT homozygotes, TC heterozygotes and CC homozygotes – 33; 50 and 12 %, respectively. CC variant of gene polymorphism CYP11B2 showed the lowest risk of myocardial infarction compared to TT + TC, while comparing postinfarction patients to healthy volunteers (Р=0.01).
Conclusion. We demonstrated the increased risk of myocardial infarction in postinfarction patients with TT + TC polymorphism of aldosterone synthase gene (CYP11B2).
Article Details
Keywords:
References
Cohn J.N., Colucci W. Cardiovascular effects of aldosterone and post-acute myocardial infarction pathophysiology // Amer. Cardiol.– 2006.– Vol. 97.– P. 4—12.
Davies E., Holloway C.D., Ingram M.C. et al. Aldosteroneexcretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2 // Hypertension.– 1999.– Vol. 33.– P. 703–707.
Duprez D.A., Bauwens F.R., De Buyzere M.L. et al. Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension // Am. J. Cardiol.– 1993.– Vol. 71.– P. 17A–20A.
Ebrahim S., Smith G.D. Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease // Brit. Med. J.– 1997.– Vol. 314.– P. 1666–1674.
Hautanen A., Lankinen I., Koskinen P. et al. Associations between human aldosteronesynthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function // Circulation.– 1998.– Vol. 97.– P. 569–575,
Kupari M., Hautanen A., Lankinen I. et al. Associations between human aldosteronesynthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function // Circulation.– 1998.– Vol. 97.– P. 569–575.
La Rovere M.T., Bigger J.T., Marcus F.I. et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction // Lancet.– 1998.– Vol. 351.– P. 478–484.
Levy D., Garrison R.J., Savage D.D. et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study // N. Engl. J. Med.– 1990.– Vol. 322.– P. 1561–1566.
Muscholl M., Schunkert H., Muders F. et al. Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension // Am. Heart J.– 1998.– Vol. 135.– P. 58–66.
Navarro-Lopez F., Coca A., Pare J.C. et al. Left ventricular hypertrophy in asymptomatic essential hypertension: its relationship with aldosterone and the increase in sodium-proton exchanger activity // Eur. Heart J.– 1993.– Vol. 14 (Suppl. J).– P. 38–41.
Schunkert H., Hengstenberg C., Holmer S.R. et al. Evaluation of the aldosterone synthase (CYP11B2) gene polymorphism in patients with myocardial infarction // Hypertension.– 2000.– Vol. 35.– P. 704–709.
Rouleau J.L., Packer M., Moye L. et al. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril // J. Am. Coll. Cardiol. 1994.– Vol. 24.– P. 583–591.
Schunkert H., Hengstenberg C., Holmer S.R. et al. Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure // Circulation.– 1999.– Vol. 99.– P. 2255–2260.
Swinfard R.W., Diaz-Arias A.A. Chronic mineralocorticoid excess and cardiovascular remodeling // Steroids.– 1995.– Vol. 60.– P. 125–132.
Tamaki S., Iwai N., Tsujita Y., Kinoshita M. Genetic polymorphism of CYP11B2 gene and hypertension in Japanese // Hypertension.– 1999.– Vol. 33.– P. 266–270.
Weber K.T., Sun Y., Campbell S.E. et al. Chronic mineralocorticoid excess and cardiovascular remodeling // Steroids.– 1995.– Vol. 60.– P. 125–132.
White P.C. Disorders of aldosterone biosynthesis and action // N. Engl. J. Med. 1994.– Vol. 331.– P. 250–258.